The forecast for respiratory system medicine use in the UK suggests a gradual decrease over the next five years from 2024 to 2028. The usage values in Units Per Thousand Persons Per Day indicate a decline from 95.9 in 2024 to 91.8 in 2028. Compared to 2023, the compound annual growth rate (CAGR) demonstrates an average yearly reduction, reflecting consistent year-on-year decline percentages. Over the past two years, the variation shows a notable downward trend.
Future trends to watch for include advancements in respiratory treatments that may either curb or reverse the declining usage trend. Additionally, attention should be given to public health initiatives, environmental changes, and demographic shifts, which can significantly influence respiratory medicine consumption patterns in the coming years.
